The University of California, Davis was awarded a $464,234 federal Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to investigate the role of the TP53 P72R single nucleotide polymorphism in high-grade serous carcinoma. The project has a performance period from November 1, 2024 to October 31, 2026. As a prominent public research university, UC Davis leverages its extensive...
This federal Project Grant award, totaling $1,163,420.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to the University of California, Davis. The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The research aims to investigate functional and phenotypic metabolic transitions governing disease state in clear cell renal cell...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,801,179.00 to the University of California, Davis (UC Davis) to conduct research on the "CONTRIBUTION OF BONE MASS AND FRACTURE TO BONE METASTASIS IN PROSTATE CANCER". The award, which runs from April 15, 2025 to April 14, 2028, supports advanced biomedical research focused on transforming healthcare for military...
The University of California, Davis was awarded a $1,298,836 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development (CFDA 12.420) federal grant program. The award, granted on November 1, 2024, supports advanced biomedical research focused on toxic products of combustion in burn and smoke inhalation injuries. As a prominent research university, UC Davis will leverage its comprehensive research infrastructure and multidisciplinary expertise to...
This federal Project Grant award in the amount of $442,750.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, with a performance period from February 1, 2025 to January 31, 2027, will support research by the University of California, Davis to determine the role of histone lactylation in post-traumatic osteoarthritis and arthritic pain. As a prominent public research university, UC Davis has extensive expertise in...
The University of California, Davis was awarded a $1,446,250 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to conduct research on "THERAPEUTIC TARGETING OF A NOVEL TUMOR-INTRINSIC SIGNALING PATHWAY FOR LETHAL PROSTATE CANCER." The award period is from August 1, 2023 to July 31, 2026. UC Davis will leverage its expertise in medical research to investigate potential medical solutions relevant to the...
The federal Project Grant award of $1,008,313.00 was provided by the Defense Health Agency through the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF). The grant, awarded on September 1, 2024, supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The award will fund innovative scientific investigations spanning basic, applied,...
This federal Project Grant award from the Department of the Army Medical Command (CFDA 12.420 - Military Medical Research and Development) provides $361,931 to the University of California, San Diego (UCSD) to investigate microglia dysfunction in MEF2C deficiency autism spectrum disorder, with the goal of discovering new targeted therapies. The award period runs from September 30, 2024 to September 29, 2027. UCSD, a leading academic research institution, will leverage its expertise in...
The University of California, Davis (UC Davis) has been awarded a $1,000,000 federal Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) for the "THE GOOD LIFE HEALTHY AGING PROGRAM TO PREVENT COGNITIVE IMPAIRMENT IN DIVERSE VETERAN COMMUNITIES: AN EMBEDDED PRAGMATIC CLINICAL TRIAL". The grant, which runs from May 1, 2024 to April 30, 2027, will fund research aimed at improving health outcomes for...
The University of California, Davis was awarded a $1,177,500 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year grant will fund research to target a key tumor plasticity driver in lethal prostate cancer. Through August 2021 to July 2024, UC Davis researchers will investigate medical solutions for prostate cancer on the cellular level with the aim of transforming patient care and outcomes. The...